7 healthcare AI companies make the Forbes top 50

Dave Pearson | | Health Exec |
Artificial Intelligence

Forbes has selected 50 AI startups from 400 or so entrants as America’s “most promising” AI companies. Seven of the 50 are in healthcare.

The seven and their subcategories within healthcare are:

  • Atomwise (drug discovery)
  • Biofourmis (patient monitoring via wearables)  
  • Genesis Therapeutics (drug discovery)
  • Karius (blood-pathogen analysis)
  • Recursion (drug discovery)  
  • twoXAR (drug discovery)  
  • Viz.ai (imaging interpretation)
AI 50: America’s Most Promising Artificial Intelligence Companies

Forbes says its scoring system combines algorithmic quantification with human judgment.

One of the human judges, Caltech professor and Nvidia researcher Anima Anandkumar, says the whittling process looked past the technological marvels in order to “focus on the problem and impact side.”

Read the rest and see the full list:

Dave Pearson
Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business
FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Design by Adaptive Theme